A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

Condition:   Cheek Volume Augmentation Interventions:   Device: VP1 Lido US;   Device: Restylane Lyft Lidocaine Sponsor:   Merz North America, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Lidoderm | Research | Study